An enhanced sensitivity to EZH2 inhibition was reported in mesothelioma cells lacking BAP1 [18], and related to enhanced expression of SETD8, a methyl transferase that decreased EZH2 expression and further restricted cell proliferation in these cells. Here, EZH2 is linked to mesothelioma.